Dunn Edmund
SEC CIK 1989401 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | Principal Accounting Off | 22.6K | — | $503.3K | 8 | 2024-06-03 | 2026-03-04 |
Most active insiders at GLUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Janku Filip | Chief Medical Off | — | $1.38M |
| 2 | Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| 3 | Dunn Edmund | Principal Accounting Off | — | $483.1K |
| 4 | Townson Sharon | CSO | — | $423.9K |
| 5 | Manning Anthony M. | Dir | — | $411.2K |
| 6 | Champoux Jennifer | COO | — | $311.3K |
| 7 | Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| 8 | Bowen Matthew | Principal Accounting Off | — | — |
| 9 | Behbahani Ali | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | 2026-03-04 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | S - Sale | $17.96 | -139 | 22.6K | -0.6% | -$2,496 | |
| DM | 2026-03-02 | 2026-02-27+ | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | S - Sale+OE | $18.09 | -25.7K | 22.7K | -53% | -$464.8K |
| DM | 2026-03-02 | 2026-02-27+ | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | M - OptEx | $13.41 | +25.7K | 47.9K | +116% | +$344.6K |
| 2026-01-05 | 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | S - Sale | $15.17 | -1,039 | 22.7K | -4% | -$15.8K | |
| 2025-06-04 | 2025-06-03 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | S - Sale | $4.45 | -2,062 | 23.7K | -8% | -$9,176 | |
| D | 2025-01-06 | 2025-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | A - Grant | — | +11.8K | 25.8K | +85% | — |
| 2024-07-09 | 2024-07-05 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | S - Sale | $3.83 | -1,610 | 13.9K | -10% | -$6,166 | |
| 2024-06-05 | 2024-06-03 | GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Off | S - Sale | $4.04 | -1,207 | 15.6K | -7% | -$4,876 |
Purchase Sale Sale after option exercise All abbreviations